Creo Medical Group PLC Share Price
Stocks
CREO
GB00BZ1BLL44
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.25 GBX | 0.00% |
|
-3.39% | +43.94% |
| 06-29 | Secure Trust starts buyback; Smiths News contract win | AN |
| 05-22 | Creo Medical Group PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 64M 85.89M 75.13M 69.3M 121M 8.19B 123M 828M 325M 4.04B 322M 315M 13.87B | P/E 2026 * |
-5.09x | P/E 2027 * | -7.31x |
|---|---|---|---|---|---|
| Enterprise Value | 57.8M 77.57M 67.85M 62.58M 110M 7.4B 112M 748M 294M 3.64B 291M 285M 12.53B | EV / Sales 2026 * |
6.35x | EV / Sales 2027 * | 4.56x |
| Free-Float |
92.59% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Creo Medical Group PLC
| 04-28 | Creo Medical : 5 Statement of Compliance | PU |
| 25/09/25 | Creo Medical : 2025 Interim Results Presentation | PU |
| 22/09/25 | Creo Medical : Unaudited results for the six months ended 30 June 2025 | PU |
| 26/06/25 | Creo Medical : Scrutineers Report 26 June 2025 | PU |
| 30/05/25 | Creo Medical : 2024 Annual Report | PU |
| 1 week | -3.39% | ||
| Current month | -2.56% | ||
| 1 month | +7.55% | ||
| 3 months | +21.28% | ||
| 6 months | +29.55% | ||
| Current year | +43.94% |
| 1 week | 14 |  | 15 |
| 1 month | 13.25 | | 15.19 |
| Current year | 9.8 | | 18.5 |
| 1 year | 9.52 | | 18.5 |
| 3 years | 9.22 | | 50 |
| 5 years | 9.22 | | 210 |
| 10 years | 9.22 | | 250 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 11/09/2016 | |
Craig Gulliford
CEO | Chief Executive Officer | - | 31/12/2011 |
Richard Rees
DFI | Director of Finance/CFO | - | 30/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Gulliford
BRD | Director/Board Member | - | 31/12/2011 |
Richard Rees
BRD | Director/Board Member | - | 30/06/2016 |
Ivonne Cantu
BRD | Director/Board Member | 58 | 31/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-13 | Free | Chief Executive Officer | 16,072 | 0.0039% | ||
| 01-13 | Buy | Chief Executive Officer | 8,036 | 0.0019% | ||
| 01-13 | Free | Chief Financial Officer | 16,072 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.39% | +10.68% | -57.46% | 85.89M | |
| +0.05% | -0.15% | +33.69% | +0.04% | 12.51B | |
| +0.67% | -3.67% | +57.40% | +30.58% | 5.87B | |
| +2.16% | -0.14% | +10.89% | +12.12% | 5.87B | |
| +1.59% | -1.92% | - | - | 4.29B | |
| +3.82% | +5.25% | -30.55% | +12.58% | 4.26B | |
| +1.84% | -2.18% | -24.97% | -28.18% | 3.83B | |
| +2.48% | +3.12% | +11.49% | +267.07% | 1.94B | |
| -5.73% | -5.23% | -7.39% | -59.43% | 1.89B | |
| 0.00% | +1.44% | +53.57% | -2.10% | 1.56B | |
| Average | +0.68% | -0.49% | +12.76% | +19.47% | 4.21B | |
| Weighted average by Cap. | +0.98% | -0.72% | +18.22% | +15.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.1M 12.21M 10.68M 9.85M 17.27M 1.16B 17.56M 118M 46.23M 574M 45.85M 44.86M 1.97B | 14.7M 19.73M 17.26M 15.92M 27.89M 1.88B 28.36M 190M 74.68M 927M 74.07M 72.46M 3.19B |
| Net income | -11.05M -14.83M -12.97M -11.96M -20.97M -1.41B -21.32M -143M -56.14M -697M -55.68M -54.47M -2.4B | -8.45M -11.34M -9.92M -9.15M -16.03M -1.08B -16.3M -109M -42.93M -533M -42.58M -41.65M -1.83B |
| Net Debt | -6.2M -8.32M -7.28M -6.71M -11.76M -794M -11.96M -80.21M -31.5M -391M -31.24M -30.56M -1.34B | 3.1M 4.16M 3.64M 3.36M 5.88M 397M 5.98M 40.1M 15.75M 195M 15.62M 15.28M 672M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | GBX 14.25 | 0.00% | 131,916 |
| 09/07/26 | GBX 14.25 | -0.87% | 256,020 |
| 08/07/26 | GBX 14.38 | -0.86% | 557,873 |
| 07/07/26 | GBX 14.50 | -1.69% | 578,346 |
| 06/07/26 | GBX 14.75 | 0.00% | 1,162,554 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CREO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition